106 related articles for article (PubMed ID: 28377924)
1. CYP1B1 G199T Polymorphism Affects Prognosis of NSCLC Patients with the Potential to Be an Indicator and Target for Precise Drug Intervention.
Li F; Zhang S; Zhang Q; Li J; Zhao S; Gu C
Biomed Res Int; 2017; 2017():1529564. PubMed ID: 28377924
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P1B1 (CYP1B1) polymorphisms and cancer risk: a meta-analysis of 52 studies.
Li C; Long B; Qin X; Li W; Zhou Y
Toxicology; 2015 Jan; 327():77-86. PubMed ID: 25434509
[TBL] [Abstract][Full Text] [Related]
3. Effect of thymidylate synthase gene polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer patients.
Dong H; Bao D; Guo X; Hu J; Li X; Wan S; Xing J
Tumour Biol; 2015 Sep; 36(9):7151-7. PubMed ID: 25877757
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
[TBL] [Abstract][Full Text] [Related]
5. Genetic Association of CYP1B1 4326 C>G Polymorphism with Disease-Free Survival in TNBC Patients Undergoing TAC Chemotherapy Regimen.
Abdul Aziz AA; Md Salleh MS; Yahya MM; Zakaria AD; Ankathil R
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1319-1324. PubMed ID: 33906328
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations associated with postoperative recurrence in stage I non-small cell lung cancer.
Yoon KA; Jung MK; Lee D; Bae K; Joo JN; Lee GK; Lee HS; Lee JS
Clin Cancer Res; 2014 Jun; 20(12):3272-9. PubMed ID: 24737549
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the CYP1B1 gene and hepatocellular carcinoma risk in a Chinese population.
Liu F; Luo LM; Wei YG; Li B; Wang WT; Wen TF; Yang JY; Xu MQ; Yan LN
Gene; 2015 Jun; 564(1):14-20. PubMed ID: 25796598
[TBL] [Abstract][Full Text] [Related]
8. The role of adiponectin (ADIPOQ) gene polymorphisms in the susceptibility and prognosis of non-small cell lung cancer.
Cui E; Deng A; Wang X; Wang B; Mao W; Feng X; Hua F
Biochem Cell Biol; 2011 Jun; 89(3):308-13. PubMed ID: 21619462
[TBL] [Abstract][Full Text] [Related]
9. Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.
Liu JY; Yang Y; Liu ZZ; Xie JJ; Du YP; Wang W
Mol Genet Genomics; 2015 Apr; 290(2):739-65. PubMed ID: 25475389
[TBL] [Abstract][Full Text] [Related]
10. Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: A case control study.
Rafrafi A; Chahed B; Kaabachi S; Kaabachi W; Maalmi H; Hamzaoui K; Sassi FH
Hum Immunol; 2013 Oct; 74(10):1368-74. PubMed ID: 23831257
[TBL] [Abstract][Full Text] [Related]
11. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
13. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
[TBL] [Abstract][Full Text] [Related]
14. Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer.
Glubb DM; Paré-Brunet L; Jantus-Lewintre E; Jiang C; Crona D; Etheridge AS; Mirza O; Zhang W; Seiser EL; Rzyman W; Jassem J; Auman T; Hirsch FR; Owzar K; Camps C; Dziadziuszko R; Innocenti F
J Thorac Oncol; 2015 Jul; 10(7):1067-75. PubMed ID: 26134224
[TBL] [Abstract][Full Text] [Related]
15. ssociation of Cytochrome P450-1B1 Gene Polymorphisms with Risk of Breast Cancer: an Egyptian Study.
Ibrahim MH; Rashed RA; Hassan NM; Al-Azhary NM; Salama AI; Mostafa MN
Asian Pac J Cancer Prev; 2016; 17(6):2861-6. PubMed ID: 27356703
[TBL] [Abstract][Full Text] [Related]
16. Association between CYP1B1 gene polymorphisms and risk factors and susceptibility to laryngeal cancer.
Yu PJ; Chen WG; Feng QL; Chen W; Jiang MJ; Li ZQ
Med Sci Monit; 2015 Jan; 21():239-45. PubMed ID: 25619313
[TBL] [Abstract][Full Text] [Related]
17. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H
Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
Uzunoglu FG; Kaufmann C; Wikman H; Güngör C; Bohn BA; Nentwich MF; Reeh M; Pantel K; Bockhorn M; Kutup A; Mann O; Izbicki JR; Vashist YK
Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975
[TBL] [Abstract][Full Text] [Related]
19. Variant of BCL3 gene is strongly associated with five-year survival of non-small-cell lung cancer patients.
Dimitrakopoulos FI; Antonacopoulou AG; Kottorou A; Marousi S; Koukourikou I; Kalofonou M; Panagopoulos N; Scopa C; Dougenis D; Papadaki H; Papavassiliou AG; Kalofonos HP
Lung Cancer; 2015 Sep; 89(3):311-9. PubMed ID: 26122346
[TBL] [Abstract][Full Text] [Related]
20. Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
Tan X; Wu Q; Cai Y; Zhao X; Wang S; Gao Z; Yang Y; Li X; Qian J; Wang J; Su B; Chen H; Han B; Jiang G; Lu D
Clin Lung Cancer; 2014 Jan; 15(1):67-78.e12. PubMed ID: 24220096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
